Diffuse myocardial fibrosis in severe aortic stenosis: An equilibrium contrast cardiovascular magnetic resonance study

European Heart Journal Cardiovascular Imaging

Volumn 13, Issue 10, 2012, Pages 819-826

  Flett, Andrew S ^a,b   Sado, Daniel M ^a,b   Quarta, Giovanni ^a,c   Mirabel, Mariana ^a,d   Pellerin, Denis ^a   Herrey, Anna S ^a   Hausenloy, Derek J ^a,b   Ariti, Cono ^e   Yap, John ^a   Kolvekar, Shyam ^a   Taylor, Andrew M ^b   Moon, James C ^a,b  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Aortic stenosis; Cardiovascular magnetic resonance; Fibrosis

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; GADOTERATE MEGLUMINE;

ADULT; AGED; AORTA STENOSIS; AORTA VALVE REPLACEMENT; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR MAGNETIC RESONANCE; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; EQUILIBRIUM CONTRAST CARDIOVASCULAR MAGNETIC RESONANCE; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL;

AGED; AORTIC VALVE STENOSIS; CONTRAST MEDIA; DISEASE PROGRESSION; ENDOMYOCARDIAL FIBROSIS; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEMODYNAMICS; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC;

EID: 84867545162     PISSN: 20472404     EISSN: None     Source Type: Journal    
DOI: 10.1093/ehjci/jes102     Document Type: Article

References (23)

1. Fact Sheet No. 310: Global Burden of Disease update. In: World Health Organization (ed.); 2008.
2. Lindroos M, Kupari M, Heikkila J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol 1993;21:1220-5. (Pubitemid 23106200)
3. Hachicha Z, Dumesnil JG, Bogaty P, Pibarot P. Paradoxical low-flow, low-gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival. Circulation 2007;115:2856-64. (Pubitemid 46869673)
4. Minners J, Allgeier M, Gohlke-Baerwolf C, Kienzle RP, Neumann FJ, Jander N. Inconsistencies of echocardiographic criteria for the grading of aortic valve stenosis. Eur Heart J 2008;29:1043-8. (Pubitemid 351844672)
5. Heymans S, Schroen B, Vermeersch P, Milting H, Gao F, Kassner A et al. Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart. Circulation 2005;112:1136-44. (Pubitemid 41216120)
6. Hein S. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 2003;107:984-91. (Pubitemid 36258721)
7. Weidemann F, Herrmann S, Stork S, Niemann M, Frantz S, Lange V et al. Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis. Circulation 2009;120:577-84.
8. Flett AS, Hayward MP, Ashworth MT, Hansen MS, Taylor AM, Elliott PM et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis preliminary validation in humans. Circulation 2010; 122:138-44.
9. de Arenaza DP, Pepper J, Lees B, Rubinstein F, Nugara F, Roughton M et al. Preoperative 6-minute walk test adds prognostic information to Euroscore in patients undergoing aortic valve replacement. Heart 2010;96:113-7.
10. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-63. (Pubitemid 41821197)
11. Paulus WJ, Tschope C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007;28:2539-50. (Pubitemid 47614269)
12. Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. J Cardiovasc Magn Reson 2008;10:35.
13. Flett AS, Hasleton J, Cook C, Hausenloy D, Quarta G, Ariti C et al. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. J Am Coll Cardiol Img 2011;4: 150-6.
14. Rasband W. ImageJ, National Institute of Health. http://rsb.info.nih.gov/ ij/.
15. Mcgraw K, Wong S. Forming inferences about some intraclass correlation coefficients. Psychol Methods 1996;1:30-46. (Pubitemid 126421252)
16. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10. (Pubitemid 16134762)
17. SPSS for Windows, Rel. 17.0.0. SPSS Inc., Chicago, USA; 2008.
18. Walther T, Schubert A, Falk V, Binner C, Kanev A, Bleiziffer S et al. Regression of left ventricular hypertrophy after surgical therapy for aortic stenosis is associated with changes in extracellular matrix gene expression. Circulation 2001; 104:I-54-8.
19. Krayenbuehl HP, Hess OM, Monrad ES, Schneider J, Mall G, Turina M. Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement. Circulation 1989;79:744-55. (Pubitemid 19100533)
20. Krayenbuhl HP, Hess OM, Schneider J, Turina M. Regression of myocardial hypertrophy in aortic valve disease following aortic valve replacement. Schweiz Med Wochenschr 1988;118:517-21.
21. Piechnik SK, Ferreira VM, Dall'Armellina E, Cochlin LE, Greiser A, Neubauer S et al. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson 2010;12:69.
22. Schelbert E, Testa S, Meier C, Ceyrolles W, Levenson J, Blair A et al. Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus. J Cardiovasc Magn Reson 2011;13:16.
23. Krayenbuhl HP, Hess OM, Schneider J, Turina M. Regression of heart hypertrophy in patients with operated aortic valve diseases. Z Kardiol 1985;74(Suppl. 7):145-52. (Pubitemid 16173174)